Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening

被引:10
作者
Wang, Liyan [1 ]
Yang, Chunmei [1 ]
Lu, Weiqiang [1 ]
Liu, Li [1 ]
Gao, Rui [1 ]
Liao, Sha [1 ]
Zhao, Zhenjiang [1 ]
Zhu, Lili [1 ]
Xu, Yufang [1 ]
Li, Honglin [1 ]
Huang, Jin [1 ]
Zhu, Weiping [1 ]
机构
[1] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, State Key Lab Bioreactor Engn,Shanghai Key Lab Ch, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
Virtual screening; Molecular docking; Carbonic anhydrase inhibitors; Sulfonamides; PRESSURE-LOWERING AGENTS; ISOZYME-IX; AROMATIC/HETEROCYCLIC SULFONAMIDES; MOIETIES; TAIL;
D O I
10.1016/j.bmcl.2013.04.048
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Through structure-based virtual screening, some dozen of benzene sulfonamides with novel scaffolds are identified as potent inhibitors against carbonic anhydrase (CA) IX with IC50 values ranging from 2.86 to 588.34 nM. Among them, compounds 1 and 9 show high selectivity against tumor-target CA IX over CA II (the selectivity ratios are 21.3 and 136.6, respectively). The possible binding poses of hit compounds are also explored and the selectivity is elucidated by molecular docking simulations. The hit compounds discovered in this work would provide novel scaffolds for further hit-to-lead optimization. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3496 / 3499
页数:4
相关论文
共 50 条
[21]   Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors [J].
Zou, Yiquan ;
Li, Li ;
Chen, Wuyan ;
Chen, Tiantian ;
Ma, Lanping ;
Wang, Xin ;
Xiong, Bing ;
Xu, Yechun ;
Shen, Jingkang .
MOLECULES, 2013, 18 (05) :5706-5722
[22]   Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis [J].
Salmas, Ramin Ekhteiari ;
Senturk, Murat ;
Yurtsever, Mine ;
Durdagi, Serdar .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (03) :425-433
[23]   Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening [J].
Ge, Huizhen ;
Peng, Lizeng ;
Sun, Zhou ;
Liu, Huanxiang ;
Shen, Yulin ;
Yao, Xiaojun .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[24]   Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening [J].
Song, Yuwei ;
Jin, Huangtao ;
Liu, Xiaofeng ;
Zhu, Lili ;
Huang, Jin ;
Li, Honglin .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) :2078-2082
[25]   Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays [J].
Lu, Wenfeng ;
Zhang, Dihua ;
Ma, Haikuo ;
Tian, Sheng ;
Zheng, Jiyue ;
Wang, Qin ;
Luo, Lusong ;
Zhang, Xiaohu .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 :34-48
[26]   Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies [J].
Kumar, Avinash ;
Rathi, Ekta ;
Kini, Suvarna G. .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (07) :2156-2170
[27]   Discovery of potent and noncovalent KRASG12D inhibitors: Structure-based virtual screening and biological evaluation [J].
Wang, Yuting ;
Zhang, Hai ;
Li, Jindong ;
Niu, Miao-Miao ;
Zhou, Yang ;
Qu, Yuanqian .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[28]   Discovery of new multifunctional selective acetylcholinesterase inhibitors: structure-based virtual screening and biological evaluation [J].
Jiang, Cheng-Shi ;
Ge, Yong-Xi ;
Cheng, Zhi-Qiang ;
Song, Jia-Li ;
Wang, Yin-Yin ;
Zhu, Kongkai ;
Zhang, Hua .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2019, 33 (05) :521-530
[29]   Discovery of new multifunctional selective acetylcholinesterase inhibitors: structure-based virtual screening and biological evaluation [J].
Cheng-Shi Jiang ;
Yong-Xi Ge ;
Zhi-Qiang Cheng ;
Jia-Li Song ;
Yin-Yin Wang ;
Kongkai Zhu ;
Hua Zhang .
Journal of Computer-Aided Molecular Design, 2019, 33 :521-530
[30]   Virtual screening in structure-based drug discovery [J].
Barril, X ;
Hubbard, RE ;
Morley, SD .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (07) :779-791